Cargando…

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

BACKGROUND: Recently, a novel programmed cell death mechanism, Cuproptosis, has been discovered and found to play an important role in the development and progression of diverse tumors. In the present study, we comprehensively investigated the core gene of this mechanism, GLS, in breast cancer. MATE...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Danfeng, Wang, Man, Huang, Xufeng, Wang, Longbin, Liu, Ying, Zhou, Shujing, Tang, Yidan, Wang, Qi, Li, Zhengrui, Wang, Geng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10471892/ https://www.ncbi.nlm.nih.gov/pubmed/37664031 http://dx.doi.org/10.3389/fonc.2023.1220038

Ejemplares similares

Establishment of a novel lysosomal signature for the diagnosis of gastric cancer with in-vitro and in-situ validation
por: Wang, Qi, et al.
Publicado: (2023)

NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
por: Wang, Qi, et al.
Publicado: (2023)

Machine learning approach combined with causal relationship inferring unlocks the shared pathomechanism between COVID-19 and acute myocardial infarction
por: Liu, Ying, et al.
Publicado: (2023)

SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity via GLS-Mediated Glutaminolysis
por: Huang, Qiongzhen, et al.
Publicado: (2021)

Preclinical Characterization of GLS-010 (Zimberelimab), a Novel Fully Human Anti-PD-1 Therapeutic Monoclonal Antibody for Cancer
por: Lou, Beilei, et al.
Publicado: (2021)

METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression
por: Chen, Xiaoting, et al.
Publicado: (2021)

Multiomics Analysis Reveals that GLS and GLS2 Differentially Modulate the Clinical Outcomes of Cancer
por: Saha, Subbroto Kumar, et al.
Publicado: (2019)

Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells
por: Szeliga, Monika, et al.
Publicado: (2013)

GLS2 shapes ferroptosis in hepatocellular carcinoma
por: Suzuki, Sawako, et al.
Publicado: (2023)

In situ Protein Detection for Companion Diagnostics
por: Gremel, Gabriela, et al.
Publicado: (2013)

Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma
por: Ren, L., et al.
Publicado: (2020)

Regulation of Cardiac Fibroblast GLS1 Expression by Scleraxis
por: Chattopadhyaya, Sikta, et al.
Publicado: (2022)

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2015)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Capsaicin alleviates doxorubicin-induced acute myocardial injury by regulating iron homeostasis and PI3K-Akt signaling pathway
por: Wang, Longbin, et al.
Publicado: (2023)

Identification of GLS as a cuproptosis-related diagnosis gene in acute myocardial infarction
por: Liu, Zheng, et al.
Publicado: (2022)

Lactate in the tumor microenvironment: A rising star for targeted tumor therapy
por: Li, Zhangzuo, et al.
Publicado: (2023)

Discovery and Validation of a Metastasis-Related Prognostic and Diagnostic Biomarker for Melanoma Based on Single Cell and Gene Expression Datasets
por: Wan, Qi, et al.
Publicado: (2020)

Inhibition of GLS suppresses proliferation and promotes apoptosis in prostate cancer
por: Zhang, Junfeng, et al.
Publicado: (2019)

WASF2 Serves as a Potential Biomarker and Therapeutic Target in Ovarian Cancer: A Pan-Cancer Analysis
por: Yang, Xiaofeng, et al.
Publicado: (2022)

Structure and activation mechanism of the human liver-type glutaminase GLS2
por: Ferreira, Igor M., et al.
Publicado: (2021)

RandomForestsGLS: An R package for Random Forests for dependent data
por: Saha, Arkajyoti, et al.
Publicado: (2022)

The Diagnostic Value of Global Longitudinal Strain (GLS) on Myocardial Infarction Size by Echocardiography: A Systematic Review and Meta-analysis
por: Diao, Kai-yue, et al.
Publicado: (2017)

Angiofibroma of Soft Tissue: A Clinicopathological Study of Eight Cases With Emphasis on the Diagnostic Utility of Fluorescence In Situ Hybridization Detection for NCOA2 Rearrangement
por: Wang, Canming, et al.
Publicado: (2022)

Identifying Immune Cell Infiltration and Effective Diagnostic Biomarkers in Lung Adenocarcinoma by Comprehensive Bioinformatics Analysis and In Vitro Study
por: Li, Xinyan, et al.
Publicado: (2022)

Insight of novel biomarkers for papillary thyroid carcinoma through multiomics
por: Liu, Wei, et al.
Publicado: (2023)

Pan-cancer analysis reveals DDX21 as a potential biomarker for the prognosis of multiple tumor types
por: Hu, Ankang, et al.
Publicado: (2022)

Plasma Metabolomics Reveals Diagnostic Biomarkers and Risk Factors for Esophageal Squamous Cell Carcinoma
por: Yu, Mengjie, et al.
Publicado: (2022)

KNL1 is a prognostic and diagnostic biomarker related to immune infiltration in patients with uterine corpus endometrial carcinoma
por: He, Kang, et al.
Publicado: (2023)

CASP4 can be a diagnostic biomarker and correlated with immune infiltrates in gliomas
por: Tian, Guopeng, et al.
Publicado: (2023)

Brief literature review and comprehensive bioinformatics analytics unravel the potential mechanism of curcumin in the treatment of periodontitis
por: Huang, Xufeng, et al.
Publicado: (2023)

Long Non-Coding RNAs as Potential Diagnostic and Prognostic Biomarkers in Breast Cancer: Progress and Prospects
por: Lu, Cuicui, et al.
Publicado: (2021)

Plasma exosomal tRNA‐derived fragments as diagnostic biomarkers in non-small cell lung cancer
por: Zheng, Baibing, et al.
Publicado: (2022)

Editorial: Epigenetic insights into diagnostic and therapeutic applications
por: Fratta, Elisabetta, et al.
Publicado: (2023)

IL-6 Promoter Hypomethylation Acts As a Diagnostic Biomarker in Hepatitis B Virus-Associated Hepatocellular Carcinoma
por: Yang, Jie-Ru, et al.
Publicado: (2022)

EDEM2 is a diagnostic and prognostic biomarker and associated with immune infiltration in glioma: A comprehensive analysis
por: Wu, Yuxi, et al.
Publicado: (2023)

Comparison of GLS via echocardiography and tissue tracking by Cardiac Magnetic Resonance imaging
por: Tantiongco, John-Paul, et al.
Publicado: (2015)

GLS loss of function causes autosomal recessive spastic ataxia and optic atrophy
por: Lynch, David S., et al.
Publicado: (2018)

Complicated Staphylococcus aureus Bacteremia (SAB) Is Associated with Genetic Variation in GLS2
por: Fowler, Vance, et al.
Publicado: (2017)

The role of CA-125, GLS and FASN in predicting cytoreduction for epithelial ovarian cancers
por: Winarno, G. N. A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6pou8b7n6b6ngq4jut82da2fcd